TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
1.690
-0.080 (-4.52%)
At close: Aug 30, 2024, 4:00 PM
2.020
+0.330 (19.53%)
After-hours: Aug 30, 2024, 7:49 PM EDT
TNF Pharmaceuticals Employees
TNF Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 3 or -33.33% compared to the previous year.
Employees
6
Change (1Y)
-3
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,891,924
Market Cap
4.01M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6 | -3 | -33.33% |
Dec 31, 2022 | 9 | 0 | - |
Dec 31, 2021 | 9 | 3 | 50.00% |
Dec 31, 2020 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Genetic Technologies | 60 |
Healthcare Triangle | 31 |
Onconetix | 12 |
Palisade Bio | 9 |
Shuttle Pharmaceuticals Holdings | 8 |
Virpax Pharmaceuticals | 7 |
Artelo Biosciences | 6 |
TNFA News
- 10 days ago - TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline - Business Wire
- 5 weeks ago - TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today - Business Wire
- 5 weeks ago - MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc. - Business Wire
- 2 months ago - MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer - Business Wire
- 3 months ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 3 months ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 6 months ago - MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing - Business Wire
- 7 months ago - MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing - Business Wire